Lacrimal Na'urorin Kasuwancin 2020 Ta Kudin Kuɗaɗen shiga, Hasashen Tattalin Arziki & Ci gaban Yanki

Selbyville, Delaware, Amurka, Oktoba 23 2020 (Wiredrelease) Hasashen Kasuwa na Duniya, Inc -: haɓaka ɗaukar ingantaccen magani na lacrimal, don samun ingantacciyar sakamako mai haƙuri, zai haifar da haɓakar kasuwancin na'urorin lacrimal a cikin lokaci mai zuwa. Sauƙin aiwatar da waɗannan hanyoyin maganin lacrimal da ci gaban fasaha da yawa da ake gani a fagen na'urorin lacrimal ana sa ran za su fitar da kudaden shiga na kasuwa.

Tare da haɓaka hanyoyin jiyya na lacrimal, ƴan wasan masana'antu suna mai da hankali kan ƙara haɓaka samfuran samfuran su. Ana sa ran waɗannan ƙoƙarce-ƙoƙarce za su juya zuwa ga samun riba mai riba ga masana'antar gabaɗaya a cikin shekaru masu zuwa. Ɗaukar Oktoba 2019 alal misali, kamfanin harhada magunguna, AlphaMed ya sami amincewa daga FDA ta Amurka (Hukumar Abinci da Magunguna) don tallata sabon filogin sa a cikin Amurka An haɓaka matosai na musamman don shigar da su a cikin canaliculus a ƙoƙarin hana lubricating hawaye daga. saukowa ta fuskar ido.

Nemi samfurin kwafin wannan rahoton @ https://www.gminsights.com/request-sample/detail/4811

A cewar wani GMI Inc., rahoton bincike, masana'antar na'urorin lacrimal na iya zarce ƙimar dala miliyan 200 a ƙarshen 2026. Ana hasashen kasuwar za ta faɗaɗa cikin ƙimar girma mai kyau na kusan 4.2% ta hanyar lokacin bincike.

Game da samfur, ana raba kasuwa cikin bututu, saitin intubation, matosai, dilator, cannula da spatula, stent, da sauransu. Daga cikin waɗannan, ɓangaren matosai ana hasashen zai lura da buƙatu mai mahimmanci a nan gaba saboda karuwar yawan aikin tiyatar idanu a duk faɗin duniya. A zahiri, a cikin 2019, ɓangaren ya ƙididdige ƙimar ƙimar dala miliyan 25.9. Punctal matosai suna shaida buƙatu mai yawa saboda ana iya shigar da su cikin sauƙi cikin ido. Wadannan matosai kuma suna yin tsayayya da ƙaura, suna rage bushewar bayyanar ido, kuma suna taimaka wa majiyyaci wajen riƙe hawaye. Bugu da kari, saurin girma a cikin adadin jariran da ke fama da toshewar bututun nasolacrimal ana hasashen tura girman sashi a cikin shekaru masu zuwa.

An rarraba masana'antar na'urorin lacrimal zuwa epiphora, bushe ido, kumburin lacrimal, toshewar magudanar ruwa, glaucoma, da sauransu dangane da sashin aikace-aikacen. Daga cikin waɗannan, ɓangaren epiphora ya ba da gudummawar ƙima mai mahimmanci na dala miliyan 14.8 a cikin 2019 kuma yana iya nuna irin wannan yanayin girma ta hanyar lokacin hasashen. An danganta haɓakar haɓakar haɓakar rashin magudanar ruwa a cikin haɗin gwiwa tare da cututtukan fatar ido, reflux hypersecretion, da sauran abubuwan muhalli. Bugu da ƙari kuma, haɓakar cututtukan ido a cikin ƙasashe masu tasowa yakamata ya haifar da hangen nesa a cikin lokacin bincike.

A halin yanzu, kasancewar wani babban tafkin mara lafiya, wanda ke da alaƙa da nau'ikan cututtukan ido daban-daban, a cikin ƙasashe masu yawan jama'a kamar China da Indiya za su fi son haɓaka kasuwar na'urorin lacrimal na Asiya Pacific. A zahiri, ana hasashen kasuwar yanki za ta faɗaɗa a cikin mahimmin ƙimar 5.3% ta cikin lokuta masu zuwa. Ɗaukar 2017 misali, mutanen da ke fama da DED (bushewar cutar ido) sun kasance daga 18.4% zuwa 54.3% a Indiya. Haɓaka yawan busassun cututtukan ido tare da haɓaka saka hannun jari a cikin kayayyakin kiwon lafiya a yankin zai inganta girman kasuwar yankin. Bugu da ƙari, ƙaƙƙarfan kasancewar masana'antun yanki a duk faɗin kudu maso gabashin Asiya yakamata ya ƙara haɓaka girman masana'antar lacrimal na Asiya Pacific.

Neman keɓancewa @ https://www.gminsights.com/roc/4811

Hakazalika, an yi hasashen karuwar yawan aikin tiyatar idanu da ake yi kowace shekara zai tura kasuwar na'urorin lacrimal a nan gaba. A gaskiya ma, a cewar Cibiyar Ido ta Stein, ana yin aikin tiyatar ido kusan 700,000 kowace shekara. Bugu da ƙari, Amurka kaɗai ta ba da rahoton raunin ido sama da miliyan 2.5. Ganin yadda hanyoyin kiwon lafiyar da ke da alaƙa da ido ke yaɗuwa, an saita ɗaukar na'urorin lacrimal don haɓaka sosai a cikin shekaru masu zuwa.  

Yanayin gasa na masana'antar na'urorin lacrimal ya haɗa da 'yan wasa kamar JEDMED, Bess Medical Technology gmbh, Rumex International, Lacrimedics, BVI, Cook Group, Kaneka Corporation, da FCI Ophthalmic da sauransu.  

Babin Sashi na Teburin entunshi 

Babi na 5. Kasuwar Na'urorin Lacrimal, Ta Aikace-aikace

5.1. Yanayin maɓallin keɓaɓɓu

5.2. bushewar ido

5.2.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan)

5.3. Epiphora

5.3.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan)

5.4. Glaucoma

5.4.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan)

5.5. Toshewar magudanar ruwa

5.5.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan)

5.6. Lacrimal kumburi kumburi

5.6.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan)

5.7. Sauran

5.7.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan)

Babi na 6. Kasuwar Na'urorin Lacrimal, Ta Ƙarshen Amfani   

6.1. Yanayin maɓallin keɓaɓɓu

6.2. Asibitoci

6.2.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan)

6.3. Asibitin ido

6.3.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan)

6.4. Cibiyoyin bincike

6.4.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan)

6.5. Sauran

6.5.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan) 

Binciko cikakken abin da ke ciki (TOC) na wannan rahoton @ https://www.gminsights.com/toc/detail/lacrimal-devices-market

An wallafa wannan abun ta kamfanin Global Market Insights, kamfanin Inc. Ma'aikatar Labaran WiredRelease ba ta shiga cikin ƙirƙirar wannan ƙunshiyar ba. Don binciken sabis na sakin latsawa, da fatan za a same mu a [email kariya].